SCHEMBL25964282

SCHEMBL25964282

CCC1O[C@H](OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(=O)[nH]c(N)nc43)[C@@H](O)[C@H]2O)C(O)C(O)[C@@H]1O

nearest known ligand 0.74

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FUT5 Q11128 1/20 0.74
TGM2 P21980 1/20 0.70
KRAS P01116 5/20 0.66
NT5E P21589 1/20 0.66
P2RX3 P56373 2/20 0.61
P2RY2 P41231 3/20 0.60
P2RY4 P51582 1/20 0.60
P2RY6 Q15077 1/20 0.60
DCPS Q96C86 1/20 0.60
HINT1 P49773 1/20 0.59
P2RY1 P47900 3/20 0.57
SRC P12931 1/20 0.57
P2RX1 P51575 1/20 0.57
P2RX4 Q99571 1/20 0.57
P2RX2 Q9UBL9 1/20 0.57
ALDH1A1 P00352 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
IMPDH2 P12268 1/20 0.57
IMPDH1 P20839 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27413479 1.00 FUT5 (0.74) FUT5TGM2KRASNT5EP2RX3
SCHEMBL29393705 0.93 FUT5 (0.73) FUT5TGM2KRASNT5EP2RX3
SCHEMBL29581866 0.93 FUT5 (0.73) FUT5TGM2KRASNT5EP2RX3
SCHEMBL29527687 0.93 FUT5 (0.73) FUT5TGM2KRASNT5EP2RX3
SCHEMBL30646153 0.93 FUT5 (0.73) FUT5TGM2KRASNT5EP2RX3
SCHEMBL29351374 0.93 FUT5 (0.73) FUT5TGM2KRASNT5EP2RX3
SCHEMBL30973673 0.93 FUT5 (0.73) FUT5TGM2KRASNT5EP2RX3
SCHEMBL29391942 0.93 FUT5 (0.73) FUT5TGM2KRASNT5EP2RX3
SCHEMBL29375573 0.93 FUT5 (0.73) FUT5TGM2KRASNT5EP2RX3
SCHEMBL29456613 0.93 FUT5 (0.73) FUT5TGM2KRASNT5EP2RX3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023141856-A1 CD3-TARGETING MULTISPECIFIC ANTIBODY AND USE THEREOF 岩唐生物科技(杭州)有限责任公司 2023-08-03 WO disclosed
WO-2023065137-A1 SITE-SPECIFIC GLYCOPROTEIN CONJUGATES AND METHODS FOR MAKING THE SAME GLYCO-THERAPY BIOTECHNOLOGY CO., LTD. (CN) 2023-04-27 WO disclosed